11 May 2017 - The world needs greater transparency on the pricing of medicines, and an overhaul of some approaches, in order to increase access to life-saving drugs, global health experts said on Thursday. 

Drug makers are under growing fire as a wave of new treatments for serious conditions like cancer and hepatitis C come to market at sky-high prices, putting them out of reach of many patients and national health services. 

"The problem has become global," said Suzanne Hill, head of essential medicines at the World Health Organisation.

Read Nasdaq article